2025
SJR Q2
JCR Q3 · 2,1
8 eşleşen makale
SCIE
Dergi ayrıntısı
Immunogenetics
- Yayıncı
- Springer Science and Business Media Deutschland GmbH
- Ülke
- Germany · Western Europe
- Tür
- journal
- ISSN
-
0093771114321211
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,804
- Quartile Q2
- H-Index 104
- Atıf/yayın 2,14
- Doküman (3y) 120
- Atıf (3y) 275
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,1
- 5Y JIF 2,7
- JCI 0,54
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Genetics Q2
- Immunology Q3
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
WoS kategorileri
- Genetics & Heredity | Immunology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 0,804 | 2,1 | 2,7 | 0,54 | Q3 | 104 |
| 2024 | Q2 | Q2 | 0,755 | 2,9 | 2,7 | 0,64 | Q3 | 104 |
| 2023 | Q2 | Q2 | 0,74 | 2,9 | 2,6 | 0,58 | Q3 | 104 |
| 2022 | Q3 | Q2 | 0,632 | 3,2 | 2,6 | 0,53 | Q3 | 104 |
| 2021 | Q2 | Q3 | 0,814 | 3,3 | 2,8 | 0,51 | Q3 | 104 |
| 2020 | Q2 | Q3 | 1,003 | 2,8 | 2,8 | 0,6 | Q3 | 104 |
| 2019 | Q2 | Q3 | 0,956 | 2,6 | 2,1 | 0,55 | Q3 | 104 |
| 2018 | — | Q3 | — | 2,5 | 2,1 | 0,56 | Q3 | — |
| 2017 | Q3 | Q3 | 0,916 | 2,1 | 2 | 0,58 | Q3 | 104 |
| 2016 | Q2 | Q3 | 1,249 | 2,1 | 2,2 | — | — | 104 |
| 2015 | Q2 | Q3 | 1,573 | 2,3 | 2,4 | — | — | 104 |
| 2014 | Q2 | Q3 | 1,228 | 2,2 | 2,3 | — | — | 104 |
| 2013 | Q2 | Q3 | 1,303 | 2,5 | 2,5 | — | — | 104 |
| 2012 | Q2 | Q2 | 1,382 | 2,9 | 2,9 | — | — | 104 |
| 2011 | Q2 | Q2 | 1,32 | 2,9 | 2,7 | — | — | 104 |
| 2010 | Q2 | Q2 | 1,217 | 2,9 | 2,7 | — | — | 104 |
| 2009 | — | Q2 | — | 3 | 2,8 | — | — | — |
| 2008 | — | Q2 | — | 2,8 | 2,6 | — | — | — |
| 2007 | — | Q2 | — | 2,7 | 2,8 | — | — | — |
| 2006 | — | Q2 | — | 2,9 | — | — | — | — |
| 2005 | — | Q2 | — | 3 | — | — | — | — |
| 2004 | — | Q2 | — | 2,9 | — | — | — | — |
| 2003 | — | Q2 | — | 2,7 | — | — | — | — |
| 2002 | — | Q2 | — | 2,5 | — | — | — | — |
| 2001 | — | Q2 | — | 2,3 | — | — | — | — |
| 2000 | — | Q2 | — | 2,1 | — | — | — | — |
| 1999 | — | Q1 | — | 2,9 | — | — | — | — |
| 1998 | — | Q2 | — | 2,3 | — | — | — | — |
| 1997 | — | Q1 | — | 3,3 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 125/192 |
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q3 | 142/183 |
| 2024 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 76/192 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 99/183 |
| 2023 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 81/191 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/181 |
| 2022 | GENETICS & HEREDITY | SCIE | Q2 | Q3 | 78/171 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q3 | 110/161 |
| 2021 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 93/175 |
| 2021 | IMMUNOLOGY | SCIE | Q3 | Q3 | 119/162 |
| 2020 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 102/176 |
| 2020 | IMMUNOLOGY | SCIE | Q3 | Q3 | 120/162 |
| 2019 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 100/178 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 108/159 |
| 2018 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 97/174 |
| 2018 | IMMUNOLOGY | SCIE | Q3 | Q3 | 113/158 |
| 2017 | GENETICS & HEREDITY | SCIE | Q3 | Q3 | 105/171 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q3 | 120/155 |
| 2016 | GENETICS & HEREDITY | SCIE | Q3 | — | 105/167 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 116/151 |
| 2015 | GENETICS & HEREDITY | SCIE | Q3 | — | 93/166 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 100/151 |
| 2014 | GENETICS & HEREDITY | SCIE | Q3 | — | 99/167 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 99/148 |
| 2013 | GENETICS & HEREDITY | SCIE | Q3 | — | 90/165 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 82/144 |
| 2012 | GENETICS & HEREDITY | SCIE | Q2 | — | 68/161 |
| 2012 | IMMUNOLOGY | SCIE | Q2 | — | 68/137 |
| 2011 | GENETICS & HEREDITY | SCIE | Q2 | — | 64/158 |
| 2011 | IMMUNOLOGY | SCIE | Q3 | — | 73/139 |
| 2010 | GENETICS & HEREDITY | SCIE | Q2 | — | 68/156 |
| 2010 | IMMUNOLOGY | SCIE | Q2 | — | 63/134 |
| 2009 | GENETICS & HEREDITY | SCIE | Q2 | — | 62/146 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 56/128 |
| 2008 | GENETICS & HEREDITY | SCIE | Q2 | — | 63/138 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 59/121 |
| 2007 | GENETICS & HEREDITY | SCIE | Q2 | — | 66/132 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 55/119 |
| 2006 | GENETICS & HEREDITY | SCIE | Q2 | — | 57/131 |
| 2006 | IMMUNOLOGY | SCIE | Q2 | — | 49/117 |
| 2005 | GENETICS & HEREDITY | SCIE | Q2 | — | 55/124 |
| 2005 | IMMUNOLOGY | SCIE | Q2 | — | 43/115 |
| 2004 | GENETICS & HEREDITY | SCIE | Q2 | — | 48/120 |
| 2004 | IMMUNOLOGY | SCIE | Q2 | — | 37/111 |
| 2003 | GENETICS & HEREDITY | SCIE | Q2 | — | 49/120 |
| 2003 | IMMUNOLOGY | SCIE | Q2 | — | 40/114 |
| 2002 | GENETICS & HEREDITY | SCIE | Q2 | — | 52/115 |
| 2002 | IMMUNOLOGY | SCIE | Q2 | — | 44/119 |
| 2001 | GENETICS & HEREDITY | SCIE | Q3 | — | 57/113 |
| 2001 | IMMUNOLOGY | SCIE | Q2 | — | 48/114 |
| 2000 | GENETICS & HEREDITY | SCIE | Q2 | — | 53/114 |
| 2000 | IMMUNOLOGY | SCIE | Q2 | — | 54/116 |
| 1999 | GENETICS & HEREDITY | SCIE | Q2 | — | 33/105 |
| 1999 | IMMUNOLOGY | SCIE | Q1 | — | 24/115 |
| 1998 | GENETICS & HEREDITY | SCIE | Q2 | — | 33/103 |
| 1998 | IMMUNOLOGY | SCIE | Q2 | — | 33/120 |
| 1997 | GENETICS & HEREDITY | SCIE | Q1 | — | 20/90 |
| 1997 | IMMUNOLOGY | SCIE | Q1 | — | 19/117 |